Steven Cohen Penumbra Inc Call Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $2.95 Million - $3.66 Million	13,400 Added 67.0%	33,400 $7.45 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $562,464 - $806,682	3,100 Added 18.34%	20,000 $5.03 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $4.07 Million - $5.73 Million	16,900 New	16,900 $4.09 Million

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.